A Phase 2 interventional study of Nutralin in Diabetes, sponsored by Avera McKennan Hospital & University Health Center. Withdrawn at 1 site in United States. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2015-04-22.
Sponsored by Avera McKennan Hospital & University Health Center · Phase 2, Interventional, and Treatment
The purpose of this clinical research study is to evaluate the effects an investigational food product has on the blood sugar and insulin levels in individuals with diabetes.
The investigational product has helped decrease the amount of insulin needed in treating diabetic dogs and has improved the dogs' longevity and quality of life. Observational analysis by trained veterinarians has indicated that the natural fluctuations in blood glucose levels do not exist in dogs consuming the product. An initial Phase 1 study tested the product in a brownie form. The product has been reformulated to capsule form for the Phase 2 study.
The hypothesis for this study is that diabetic individuals will decrease their insulin/diabetic medication usage and have a decrease in glucose levels after consuming the product for 16 weeks.
Avera McKennan Hospital & University Health Center is the lead sponsor of 31 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Individuals with Type 2 Diabetes
Dietary Supplement: Nutralin
Individuals with Type 2 Diabetes
Dietary Supplement: Nutralin
7 capsules taken 15 minutes before each of the three main meals of the day
Blood Sugar
blood sugar levels
Time frame: 16 weeks
HgA1c reduction
reduction of Hemoglobin A1c levels
Time frame: 16 weeks
Diabetes medication
reduction in the amount of diabetes medication needed
Time frame: 16 weeks
This study is withdrawn, as verified in Apr 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Avera McKennan Hospital & University Health Center